HER家族酪氨酸激酶抑制剂
英文名 | Canertinib (CI-1033) | CAS号 | 267243-28-7 |
试剂别名 |
Canertinib;CI-1033;PD-183805;N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide;N-[4-(3-chloro-4-fluoro-anilino)-7-(3-morpholinopropoxy)quinazolin-6-yl]acrylamide;CI-1033(Canertinib);Canertinib base;Canetinib;Canertinib (CI-1033);N-[4-(3-chloro-4-fluoroanilino)-7-(3-Morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-en;2-Propenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazoliny...;2-Propenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-;Canertinib (CI-1033,CI 1033, PD-183805, PD-0183805);N-(4-(3-Chloro-4-fluorophenylamino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide;UNII-C78W1K5ASF;N-[4-(3-Chloro-4-fluoroanilino)-7-(3-morpholinopropoxy)quinazolin-6-yl]acrylamide
|
分子式 | C24H25ClFN5O3 |
产品编号 | APEA1845 | 分子量 | 485.94 |
MDL号 | MFCD09837878 |
产品名称: | HER家族酪氨酸激酶抑制剂 |
英文名称: | Canertinib (CI-1033) |
英文别名: | Canertinib;CI-1033;PD-183805;N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide;N-[4-(3-chloro-4-fluoro-anilino)-7-(3-morpholinopropoxy)quinazolin-6-yl]acrylamide;CI-1033(Canertinib);Canertinib base;Canetinib;Canertinib (CI-1033);N-[4-(3-chloro-4-fluoroanilino)-7-(3-Morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-en;2-Propenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazoliny...;2-Propenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-;Canertinib (CI-1033,CI 1033, PD-183805, PD-0183805);N-(4-(3-Chloro-4-fluorophenylamino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide;UNII-C78W1K5ASF;N-[4-(3-Chloro-4-fluoroanilino)-7-(3-morpholinopropoxy)quinazolin-6-yl]acrylamide |
中文别名: | 卡奈替尼 |
CAS No.: | 267243-28-7 |
分子式: | C24H25CLFN5O3 |
分子量: | 485.94 |
危险品级别: | |
HS符号: | |
危害声明: |